Healthcare & Biotech active

Ultromics

10684811 First deal Feb 2018

Deals

£75M

Total Capital Raised/Funded

Deal History

VC Funding Series C 31 Jul 2025

Investor: GV, Allegis Capital, Oxford Science Enterprises, University of Chicago Medicine, L&G Capital, Blue Venture Fund, UPMC Enterprises, Oxford University, Lightrock

£42M

VC Funding Series B 16 Aug 2021

Investor: Blue Venture Fund, Optum Ventures, Oxford Sciences Innovation, GV

£24M

VC Funding Series A 1 Feb 2018

Investor: Oxford Sciences Innovation, Tanarra, Dieter Spälti., Andre Crawford-Brunt, GT Healthcare, Neptune, Fushia, RT Ventures

£10M

Funding Timeline

February 2018

VC Funding Series A £10M

Oxford Sciences Innovation, Tanarra, Dieter Spälti., Andre Crawford-Brunt, GT Healthcare, Neptune, Fushia, RT Ventures

August 2021

VC Funding Series B £24M

Blue Venture Fund, Optum Ventures, Oxford Sciences Innovation, GV

July 2025

VC Funding Series C £42M

GV, Allegis Capital, Oxford Science Enterprises, University of Chicago Medicine, L&G Capital, Blue Venture Fund, UPMC Enterprises, Oxford University, Lightrock

Financial History

Directors & Officers

Companies House